The biopharmaceutical company is developing therapeutics to treat neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system diseases, pain, and various types of cancer.
View full AVXL profile View Profile
February 12 2019
December 13 2018
October 19 2018
March 14 2016